Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: the modifying role of obesity

Back

HFA Premium Access

Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: the modifying role of obesity

Session: Chronic heart failure - pathophysiology and mechanisms 10

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor P. Palau Sampio (Valencia, ES)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Patricia Palau Sampio

Valencia University Clinical Hospital, Valencia (Spain)

1 presentation

0 follower

7 more presentations in this session

Conventional medical therapies in patients with heart failure across different risk for transthyretin amyloid cardiomyopathy in the DELIVER, PARAGON-HF and TOPCAT Americas trials

Speaker: Doctor R. Inciardi (Brescia, IT)

True prevalence of transthyretin cardiac amyloidosis in an unselected heart failure with preserved ejection fraction cohort

Speaker: Miss A. Achten (Maastricht, NL)

The value of scoring systems in terms of phenogroups in the diagnosis of heart failure with preserved ejection fraction

Speaker: Associate Professor S. Murat (Eskisehir, TR)

Inter-atrial block as a predictor of adverse outcomes in patients with HFpEF

Speaker: Miss S. Mourmans (Maastricht, NL)

Associations of peroxiredoxin-4, a circulating antioxidant, with incident heart failure

Speaker: Doctor N. Suthahar (Rotterdam, NL)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 10

Speakers: Doctor P. Palau Sampio, Doctor R. Inciardi, Miss A. Achten, Associate Professor S. Murat, Miss S. Mourmans...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources